Cemiplimab with platinum-based chemotherapy for untreated advanced non-small-cell lung cancer [ID3949]

Final draft guidance

Final draft guidance (PDF 258 KB)

Committee papers (PDF 2.61 MB)

Public committee slides (PDF 1.49 MB)

Draft guidance

Draft guidance (downloadable version) (PDF 276 KB)

Draft guidance (online commenting)

Committee papers (PDF 7.03 MB)

Public committee slides (PDF 1.1 MB)

Final scope (PDF 183 KB)

Final stakeholder list (PDF 178 KB)

Equality impact assessment (guidance development) (PDF 125 KB)

Draft matrix post referral (PDF 177 KB)